Allergy Immunotherapy Companies

  • Report ID: 3769
  • Published Date: May 12, 2025
  • Report Format: PDF, PPT

Companies Dominating the Allergy Immunotherapy Landscape

    • The competitive landscape of the allergy immunotherapy market is inspiring the global players to expand their market share. Companies involved in the emerging markets of the U.S., such as Thermo Fisher Scientific and Regeneron Pharmaceuticals, are leveraging advanced injectable treatments. While other key players, including ALK-Abelló and Stallergenes Greer, are dominating the industry with sublingual and subcutaneous treatments. This is further dragging the interest in conducting research activities and bringing innovation in the field, especially for biologics and immunotherapies targeting severe allergic reactions.

      Company Name

      Country of Origin

      Industry Focus

      ALK-Abelló A/S

      Denmark

      SLIT/SCIT therapies for pollen, mite, and food allergies

      Stallergenes Greer

      Switzerland

      Global SLIT and SCIT manufacturer, broad allergen portfolio

      Allergy Therapeutics

      UK

      SCIT and peptide-based immunotherapy

      HAL Allergy B.V.

      Netherlands

      SCIT/SLIT for airborne allergens and insect venoms

      DBV Technologies

      France

      Epicutaneous immunotherapy (EPIT) focuses on food allergy

      Jubilant HollisterStier

      USA/India

      Contract manufacturing of allergy immunotherapy products

      Circassia Group

      UK

      Biopharmaceuticals with an allergy focus (divested in recent years)

      Zydus Lifesciences

      India

      Allergy vaccines and biologics, expanding the immunotherapy line

      Biogenics Research & Training

      India

      Focused on allergy vaccine development and testing

      Inmunotek S.L.

      Spain

      Manufacturer of allergen vaccines and diagnostics

      BioPharma Laboratories

      Australia

      Allergy testing and immunotherapy production

      Curalogic A/S (defunct)

      Denmark

      Developed allergy vaccines (merged/divested)

      Alletess Medical Laboratory

      USA

      Allergy testing and personalized immunotherapy services

      Medinova Laboratories

      Malaysia

      Local manufacturer of allergy treatment solutions

      Hanmi Pharmaceutical

      South Korea

      R&D focuses on biologics, including allergy-related therapeutics

      Protherics (BTG plc)

      UK

      Allergy and venom immunotherapy (now part of BTG)

      Immunomic Therapeutics

      USA

      DNA-based immunotherapy platforms for allergies

    Below are the areas covered for each company under the top 15 global manufacturers:

    • Company Overview 
    • Business Strategy 
    • Key Product Offerings 
    • Financial Performance 
    • Key Performance Indicators 
    • Risk Analysis 
    • Recent Development 
    • Regional Presence 
    • SWOT Analysis 

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the allergy immunotherapy market was over USD 2.9 billion.

The market size for the allergy immunotherapy market is projected to reach USD 9.3 billion by the end of 2037, expanding at a CAGR of 10.1% during the forecast period, i.e., between 2025-2037.

The major players in the market are ALK-Abelló, Stallergenes Greer, Allergy Therapeutics, HAL Allergy, DBV Technologies, and others.

In terms of the allergy type segment, the allergic rhinitis segment is anticipated to garner the largest market share of 60.4% by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 51.5% by the end of 2037 and provide more business opportunities in
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos